Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no single clinically mandated time of day to take Wegovy. Because semaglutide is a once-weekly injection, the day matters more than the hour — but choosing a consistent time and day you can stick to each week is the practical key to staying on track. Here is what the evidence and guidance actually say, so you can make that choice with confidence.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've chosen Sunday as your Wegovy day, but last Sunday you did it after lunch, this Sunday it's almost bedtime, and next Sunday you're wondering whether to skip ahead because you'll be away. This kind of drift is genuinely common, and it's worth unpicking what the guidance says.
The short answer is that the time of day is not specified in the Wegovy SmPC (the Summary of Product Characteristics, the authoritative clinical document for the medicine). What is specified is that injections should be given once every seven days, and that if you need to shift your day, you can, as long as at least three days have passed since the previous dose. The NHS's semaglutide guidance reinforces this: pick a day and a time that fits your routine and stick with it as closely as possible.
So the hour of day is a lifestyle choice, not a clinical prescription. That said, the choice is still worth making deliberately, because the routine you build around your injection is what keeps treatment consistent over weeks and months.
For practical guidance on how to settle on that anchor day and time, our page on the best time of day to take Wegovy walks through the factors most people weigh up.
There is no trial data directly comparing morning versus evening injections for Wegovy. What does exist is a clear picture of the most common side effects (nausea, constipation, indigestion, fatigue) and that picture shapes what most people prefer.
GI symptoms (nausea especially) are most likely in the 12–48 hours after an injection, and they tend to be most pronounced after the first few doses or a dose increase, then settle. Because of this, many people on semaglutide choose to inject in the evening or before bed. Sleeping through the peak nausea window is a practical buffer, and it means you're not managing queasiness during a working day.
Morning injections suit others, particularly people who find they feel slightly foggy or tired after injecting and prefer that to happen overnight anyway, or simply those whose routine makes Friday morning, say, more reliably free than Friday evening. Neither is wrong.
The one thing that genuinely matters more than any timing preference is removing friction from the routine. If you are still weighing up whether there is a best time of day to take Wegovy, the answer depends more on your personal schedule than on any clinical rule. Pick a slot with no competition and set a phone reminder. That single-sentence advice is what our prescribers find makes the biggest practical difference over months of treatment.
This distinction matters, because the Wegovy treatment overview now covers two licensed forms (the weekly injection and the newer daily oral tablet) and their timing rules could not be more different.
For the injection: any time of day, with or without food, once a week. Flexible, forgiving on timing.
For the tablet: first thing in the morning, on a completely empty stomach, with no more than a small amount of plain water, and then at least 30 minutes before any food, drink (including coffee), or other oral medicines. If you take the tablet with food, or too soon before eating, semaglutide absorption drops significantly. This is a genuine clinical restriction, not a preference.
If you are considering or currently using the oral semaglutide (Wegovy tablet) route, that morning-empty-stomach rule is non-negotiable, and our dedicated page on what's the best time of day to take Wegovy explains how the answer differs depending on whether you are using the tablet or the injection. The injection version, by contrast, gives you the full day to choose from.
For more on where to access Wegovy through a regulated UK pharmacy, the Wegovy, where to buy guide covers what to look for and the questions worth asking any provider.
Timing can soften when side effects are felt; it cannot reduce whether they occur. Both semaglutide's GI side effects and its less common effects (headache, fatigue, dizziness, injection-site reactions) are driven by the medicine's mechanism and your individual response to it, not by the clock.
If side effects are persistent or severe (particularly any sustained stomach pain that radiates toward your back) that is a reason to contact your prescriber or seek prompt medical attention, not to experiment with timing. The MHRA's Yellow Card scheme allows anyone to report unexpected side effects directly to the regulator, which is worth knowing.
Our FAQs page covers the most common questions people ask in the weeks after starting, including what to expect as doses increase. If side effects are affecting your daily life, the right conversation is with a prescriber, not a forum. That's why checking your eligibility with our clinical team includes access to aftercare, seven days a week, from the people who prescribed your treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.